Top Markets
Coin of the day
ProUroCare Medical Inc. ProUroCare Medical Inc.

ProUroCare Medical Inc.

PUMD
Clasificación en acciones #42361
ProUroCare Medical Inc. is dedicated to developing advanced products for the... ProUroCare Medical Inc. is dedicated to developing advanced products for the accurate identification and detailed assessment of male prostate diseases. The company's primary offering is the ProUroScan System, an innovative prostate imaging solution. This system empowers physicians to precisely document prostate irregularities that have been initially discovered through a digital rectal examination. ProUroCare has entered into strategic agreements with Artann Laboratories Inc., covering the licensing, ongoing development, and market commercialization of its ProUroScan System. The company was established in 1999 and is headquartered in Eden Prairie, Minnesota.
Precio por acción
$0.0001
Última sincronización: 2026-08-11
Capitalización bursátil
$1.86K
Cambio (1 día)
0.00%
Cambio (1 año)
-50.00%
País
US
Comercio ProUroCare Medical Inc. (PUMD)

Categoría

EPS de ProUroCare Medical Inc. (PUMD)
EPS a fecha de 2026 TTM: 0
Según los últimos informes financieros y el precio de las acciones de ProUroCare Medical Inc., el EPS actual de la empresa (TTM) es 0. Al final del año 2026, la empresa tenía un EPS de 0 igual a al EPS de 2026, que fue de 0.
Historial de EPS de ProUroCare Medical Inc. desde 2026 hasta 2026
EPS al final de cada año
Año EPS Cambiar
Not enough data for the provided dates.
EPS de empresas similares o competidoras